Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of VIAject®7 vs VIAject®25 and Insulin Lispro in T1DM
NCT01235039Phase 2Completed
- Sponsor
- Biodel Inc.
- Start
- Jul 2009
- Primary completion
- Sep 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of VIAject in type 1 diabetes mellitus (T1D), sponsored by Biodel Inc.. Started Jul 2009; status: completed.
02
Drugs
VIAject
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01235039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235039.